On December 19, 2024, the Norwegian Medical Products Agency (NOMA) published updated guidelines on pharmaceutical marketing regulations. These updates are intended for the pharmaceutical industry, pharmacies, clinics, and other entities involved in marketing medicinal products for humans and animals. The revised guidelines introduce important changes, both linguistic and structural.

Why Is This Important?

Pharmaceutical marketing is strictly regulated to ensure that product information is accurate, balanced, and objective. The updates to the guidelines have been made in response to:

• The implementation of Regulation (EU) 2019/6 on veterinary medicinal products.
• Amendments to Chapter 13 of the Medicines Regulations.

What Does This Mean for Your Business?

For all entities engaged in pharmaceutical marketing, it is crucial to familiarise themselves with the new guidelines to ensure compliance with current regulations. Non-compliance may lead to sanctions from regulatory authorities, making it essential to stay updated.

Need Assistance?

Mericon’s marketing compliance team has extensive experience in pharmaceutical marketing and can help you understand and adapt your marketing strategies in line with the new guidelines. We offer consultancy, strategic adjustments, and content quality assurance to ensure your business remains compliant with the regulations.

For more information or guidance, contact Mericon’s marketing compliance team today!